team, innovation
Slide

Thought Leadership

Our experts share their analysis and points of view on issues happening within the market access space.

Latest Articles

nuclearmedicine_featuredimage

The Nuclear Medicine Buildout: Why the Next Wave of Radiotracers and Radioligand Therapies May Be Successful Based on Infrastructure

inofficedispensing-featuredimage

In-Office Dispensing Beyond Oncology: An Emerging Revenue Opportunity Coming into Focus

accessarchitecture_featuredimage

The Access Architecture Era: What ASCO 2026 Signals for Cell Therapies

invivocart_featuredimage

In Vivo CAR-T: The Next Inflection Point in Cell Therapy Operations

ipay2026_featuredimage

IRA Maximum Fair Price: What IPAY 2026 Reveals for Impacted Manufacturers

perceivedaccess_featuredimage

When the Access Environment Is the Problem, and When Perceived Access Is

nuclearmedicine_featuredimage

The Nuclear Medicine Buildout: Why the Next Wave of Radiotracers and Radioligand Therapies May Be Successful Based on Infrastructure

inofficedispensing-featuredimage

In-Office Dispensing Beyond Oncology: An Emerging Revenue Opportunity Coming into Focus

accessarchitecture_featuredimage

The Access Architecture Era: What ASCO 2026 Signals for Cell Therapies

invivocart_featuredimage

In Vivo CAR-T: The Next Inflection Point in Cell Therapy Operations

ipay2026_featuredimage

IRA Maximum Fair Price: What IPAY 2026 Reveals for Impacted Manufacturers

perceivedaccess_featuredimage

When the Access Environment Is the Problem, and When Perceived Access Is